Board of Directors

Dr. John Kirkwood

Usher Professor of Medicine, Dermatology and Translational Science University of Pittsburgh School of Medicine and the Co-Leader, Melanoma and Skin Cancer Program, UPMC Hillman Cancer Center

Dr. Kirkwood is internationally renowned for pioneering research in the development of biological therapies for melanoma.  He is a member of numerous medical oncology and research societies and has co-authored more than 300 peer-reviewed articles, chapters and reviews, focusing heavily upon melanoma.  In 1995, Dr. Kirkwood assumed the Chairmanship of the Eastern Cooperative Oncology Group’s Melanoma Committee.

Dr. Mohammed Kashani-Sabet

Associate Professor of Dermatology at California Pacific Medical Center, Herschel and Diana Zackheim Endowed Chair in Cutaneous Oncology, Director of CPMC Melanoma Center, and Clinical Leader of Cutaneous Oncology Program at CPMC Comprehensive Cancer Center

Dr. Kashani-Sabet’s research is focused on the prognostic approach to patients disease state and the identification of melanoma progression genes, and the development gene Therapies for patients with melanoma, areas which he has published extensively.  Dr. Kashani-Sabet is a member of numerous professional societies, and serves on the editorial board of Cancer Gene Therapy.

Dr. Renu Gupta

Executive VP of Development & Chief Medical Officer of Transave Inhalation Biotherapeutics

Dr. Gupta was formerly at Antigenics, Inc., where she was Sr. VP of Development, advancing its immunotherapy and small molecule pipeline for Oncology and Infectious Diseases.  Her work has been published in leading peer-reviewed journals, including the Journal of Infectious Diseases and she has been active in numerous relevant academic and professional societies such as the Infectious Disease Society of America and the American Academy of Pediatrics.

Dr. Howard Maibach

Professor in Department of Dermatology, School of Medicine, at University of California in San Francisco

Dr. Maibach is a recognized expert in the field of Dermatology, and specifically, dermatopharmacology and dermatotoxicology.  Dr. Maibach has published over 1700 articles on various dermatology-related subjects, and is a frequent lecturer on various subjects related to dermatology.

Valerie Guild

CoFounder & President of AIM at Melanoma Foundation

Ms. Guild holds an MBA and an MS in Education.  After spending 25 years in the private sector, Ms. Guild started working in the area of melanoma advocacy in 2003 after the death of her daughter from melanoma.

The Time is Now. Help Us Find the Cure.

Related Content

AIM Mission

AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through innovative research, legislative reform, education, and patient and caregiver support.

Get Involved

AIM is dedicated to finding the CURE by transforming clinical research.

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.